Seeing Is Believing
Analyst Andrew Paine, currently employed at CLSA,
Most recent stock forecast was given on RMD, ResMed at 11-May-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$290
$44.96 (18.35%)
$286
17 days ago
(23-Apr-2025)
14/18 (77.78%)
$53.9 (22.83%)
310
Hold
$248
$2.96 (1.21%)
$260
17 days ago
(23-Apr-2025)
1/3 (33.33%)
$11.9 (5.04%)
17
Buy
$285
$39.96 (16.31%)
$250
17 days ago
(23-Apr-2025)
5/6 (83.33%)
$48.9 (20.71%)
30
Hold
3 months 10 days ago
(30-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212
Buy
$250
$4.96 (2.02%)
$215
7 months 11 days ago
(29-Sep-2024)
11/11 (100%)
$6.95 (2.86%)
115